Pupil Centroid Shift Compensation in Photorefractive Keratectomy Candidates
NCT03844178 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 104
Last updated 2019-02-18
Summary
patients who are candidates of PRK will be recruited in this intrasubject randomized clinical trial. Inclusion criteria are myopia or myopic astigmatism with refractive cylinder. Exclusion criteria were unstable refractive error, age less than 21 years old, corneal opacity, keratoconus, keratoconus suspects, residual corneal stromal thickness less than 350 µm, moderate or severe dry eye disease and any other ocular pathology other than refractive error. Complete eye exam will be performed preoperatively including: uncorrected distance visual acuity (UDVA), best spectacle corrected distance visual acuity (CDVA), cyclorefraction, slit lamp biomicroscopy, Goldmann applannation tonometry, dual scheimpflug tomography (Ziemmer), topography in mesopic condition accompanied by pupilometry and iris registration (Topolyzer Vario, Alcon Laboratories, Inc., Fort Worth, TX), and funduscopy with dilated pupil.
Surgical Technique The same surgeon (A.F.) will perform all surgeries. After installation of Tetracaine 1%, periorbital skin will be prepared with povidone iodine 5%. Iris registration will be performed in all eyes before epithelial removal. Ethylalcohol 20.0% into a 9.0 mm well for 20 seconds will be applied on the central cornea, and then the epithelium of the central 9.0 mm area will be removed by hockey knife. In the right eye of each patient PCS compensation will be turned on (PCS-On group) and in the left eye it will be turned off (PCS-Off group). Excimer laser ablation will be performed by Wavelight Allegretto EX500 (Alcon, Fort Worth, TX, USA). Selection of which eye to be first ablated will be done randomly. Randomization will be performed based on a computer software by a Biostatistician which produced the first eye to be operated. Static cyclotorsion compensation will be active in all eyes. The ablation profile will be wavefront-optimized in all cases.
Postoperative Course Postoperatively, chloramphenicol 0.5% eye drops and betamethasone 0.1% eye drops will be prescribed every 6 hours for 10 days. Thereafter, Fluorometholone 0.1% eye drops every 6 hours for 1 month and every 8 hours for the next month will be given. Follow-up examinations were scheduled at 1, 2, 3, 4, 7 and 15 days and 1, 2, 3, and 6 months postoperatively. After contact lens removal each follow-up examination includes the UDVA, manifest refraction, and IOP measurements as well as a slit lamp biomicroscopy. Corneal imaging with Galilei tomography, CDVA and cyclorefraction will be performed at the final follow-up examination 6 months postoperatively.
Conditions
- Pupil Centroid Shift
Interventions
- PROCEDURE
-
The option for compensation of Pupil centroid shift was ON
The option for compensation of Pupil centroid shift was ON
- PROCEDURE
-
The option for compensation of Pupil centroid shift was OFF
The option for compensation of Pupil centroid shift was OFF
- DRUG
-
installation of Tetracaine 1%
installation of Tetracaine 1%
- PROCEDURE
-
Photorefractive keratectomy (PRK)
periorbital skin will be prepared with povidone iodine 5%. Iris registration will be performed in all eyes before epithelial removal. Ethylalcohol 20.0% into a 9.0 mm well for 20 seconds will be applied on the central cornea, and then the epithelium of the central 9.0 mm area will be removed by hockey knife. Excimer laser ablation will be performed by Wavelight Allegretto EX500 (Alcon, Fort Worth, TX, USA)
Sponsors & Collaborators
-
Shahid Beheshti University of Medical Sciences
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-10
- Primary Completion
- 2019-06-01
- Completion
- 2019-07-01
Countries
- Iran
Study Locations
More Related Trials
-
Mechanical Versus Alcohol Epithelial Debridement During Hotorefractive Keratectomy (PRK)
NCT00918697 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Three Vision Therapy Approaches for Convergence Insufficiency
NCT03431454 ·Status: UNKNOWN ·Phase: PHASE2
-
Corneal WFG Versus AF Trans PRK in Myopic Patients With High Corneal HOA
NCT03786861 ·Status: COMPLETED ·Phase: NA
-
Photorefractive Keratectomy (PRK) for Hyperopia After Radial Keratotomy
NCT00917657 ·Status: COMPLETED ·Phase: NA
-
Defocus Induced Changes on Choroidal Thickness
NCT03954886 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of PKP vs DSAEK in Terms of 2-year Postoperative Visual Acuity in Advanced BPK
NCT06818747 ·Status: RECRUITING ·Phase: NA
-
Surface Ablation With Corneal Cross Linking in Mild Keratoconus
NCT05176171 ·Status: UNKNOWN ·Phase: NA
-
Wavefront-guided Photorefractive Keratectomy (PRK) Versus Wavefront-guided Lasik for Myopia
NCT01140594 ·Status: COMPLETED ·Phase: NA
-
Binocular Peripheral Myopic Defocus Using a Clinical Prototype Device
NCT05425108 ·Status: UNKNOWN ·Phase: NA
-
A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia.
NCT04806503 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients
NCT02374671 ·Status: COMPLETED ·Phase: NA
-
Pilocarpine and Brimonidine in Patients With Monofocal Lenses
NCT03825081 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Orthoptic Changes Following Photorefractive Keratectomy
NCT01279993 ·Status: COMPLETED ·Phase: PHASE3
-
Corneal Endothelial Cell Injury Induced by Mitomycin-C
NCT05548478 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study
NCT02974387 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia
NCT00999973 ·Status: UNKNOWN ·Phase: PHASE1
-
Refractive Transepithelial Photo-keratectomy (T-PKR) in High Myopia
NCT04917562 ·Status: COMPLETED
-
A Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser
NCT01135719 ·Status: COMPLETED ·Phase: NA
-
Treatment of Vision Disturbances Due to Corneal Irregularities by Trans-epithelial Optical Phototherapeutic Keratectomy (TE-oPTK)
NCT03841253 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison of Cross-cylinder and Conventional Photorefractive Keratectomy(PRK) in Correcting Medium-high Astigmatism
NCT00663923 ·Status: COMPLETED ·Phase: PHASE3
-
Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa
NCT01530659 ·Status: COMPLETED ·Phase: PHASE2
-
Use of the VisuMax Femtosecond Laser Lenticule Removal Procedure for the Correction of Hyperopia
NCT03431571 ·Status: UNKNOWN ·Phase: NA
-
Adjusted Study Protocol: Within-Subject Paired-Eye Design Comparing Pilocarpine 0.1%, Phentolamine 0.75%, and Combination Therapy for Cyclopentolate Reversal in Children
NCT07012512 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children
NCT06995911 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Peripheral Relative Refractive Power of Orthokeratology Lenses
NCT07294404 ·Status: COMPLETED